Comparative study between intralesional acyclovir versus intralesional 5-flurouracil in treatment of recalcitrant warts
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-025-04298-5 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Ghada Abdel Badea Abdel Aziz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology and Venereology, Faculty of Medicine (For Girls), Al Azhar University, Cairo, Egypt. Hauptthemen laut MEDLINE: Fluorouracil, Warts, Acyclovir, Antiviral Agents. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Although different treatment modalities are available, the treatment of warts is still challenging with recalcitrant and recurrent lesions. Given that warts are viral in nature, acyclovir might be a viable treatment option. Intralesional acyclovir and 5-fluorouracil (5-FU) injections have been described for treating common warts and achieved a complete response in most of the patients. AIM: The aim of this work was to assess the efficacy and safety of intralesional acyclovir versus intralesional 5-flurouracil in treatment of recalcitrant cutaneous warts. PATIENTS AND METHODS: This comparative study was carried out on 60 patients diagnosed with recalcitrant cutaneous warts. The patients were categorized randomly into group I (30 patients treated with intralesional acyclovir) and group II (30 patients treated with intralesional 5-FU). Treatment was repeated every two weeks to a maximum of six sessions or until complete clearance occurred. Treatment response was assessed clinically and dermoscopically. This is the first randomized clinical trial comparing intralesional acyclovir with 5-FU for recalcitrant warts. RESULTS: After the end of 6 months of follow-up, complete clearance was achieved in 20 patients (66.7%) and 19 patients (63.3%) in the acyclovir and 5-FU groups, respectively. Also, complete clearance of all dermoscopic findings was observed in 66.7% of patients in the acyclovir group compared to 63.3% of patients in the 5-FU group, with no statistically significant difference between both groups (p > 0.001). Both modalities were safe and well tolerated. CONCLUSION: Intralesional acyclovir and 5-FU are safe and effective methods in treatment of recalcitrant cutaneous warts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology and Venereology, Faculty of Medicine (For Girls), Al Azhar University, Cairo, Egypt.
- Dermatology and Venereology, Faculty of Medicine (For Girls), Al Azhar University, Cairo, Egypt. Doaaabdelmelek.medg@azhar.edu.eg.
Zitieren
APA
Aziz, G. A. B. A., Pessar, D. A. E. H., Semeda, L. M. R., & Ali, M. S. A. (2025). Comparative study between intralesional acyclovir versus intralesional 5-flurouracil in treatment of recalcitrant warts. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04298-5
Vancouver
Aziz GABA, Pessar DAEH, Semeda LMR, Ali MSA. Comparative study between intralesional acyclovir versus intralesional 5-flurouracil in treatment of recalcitrant warts. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04298-5
BibTeX
@article{Aziz2025,
author = {Aziz, Ghada Abdel Badea Abdel and Pessar, Doaa Abd El-Maleek Hassan and Semeda, Leila M R and Ali, Mona S A},
title = {Comparative study between intralesional acyclovir versus intralesional 5-flurouracil in treatment of recalcitrant warts},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-025-04298-5}
}
EUVIMED